103 related articles for article (PubMed ID: 37459055)
61. Association of Physician Densities and Gynecologic Cancer Outcomes in the United States.
Smick AH; Holbert M; Neff R
Obstet Gynecol; 2022 Nov; 140(5):751-757. PubMed ID: 36201771
[TBL] [Abstract][Full Text] [Related]
62. Effect of expansions in state Medicaid eligibility on access to care and the use of emergency department services for adult Medicaid enrollees.
Ndumele CD; Mor V; Allen S; Burgess JF; Trivedi AN
JAMA Intern Med; 2014 Jun; 174(6):920-6. PubMed ID: 24710866
[TBL] [Abstract][Full Text] [Related]
63. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
Islami F; Fedewa SA; Jemal A
Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
[TBL] [Abstract][Full Text] [Related]
64. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
[TBL] [Abstract][Full Text] [Related]
65. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
Feldman CH; Hiraki LT; Liu J; Fischer MA; Solomon DH; Alarcón GS; Winkelmayer WC; Costenbader KH
Arthritis Rheum; 2013 Mar; 65(3):753-63. PubMed ID: 23203603
[TBL] [Abstract][Full Text] [Related]
66. Using HPV prevalence to predict cervical cancer incidence.
Sharma M; Bruni L; Diaz M; Castellsagué X; de Sanjosé S; Bosch FX; Kim JJ
Int J Cancer; 2013 Apr; 132(8):1895-900. PubMed ID: 22965284
[TBL] [Abstract][Full Text] [Related]
67. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
68. Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer.
Ramsey SD; Zeliadt SB; Richardson LC; Pollack LA; Linden H; Blough DK; Cheteri MK; Tock L; Nagy K; Anderson N
Breast J; 2010; 16(1):20-7. PubMed ID: 19929888
[TBL] [Abstract][Full Text] [Related]
69. State variation in the characteristics of Medicare-Medicaid dual enrollees: Implications for risk adjustment.
Roberts ET; Mellor JM; McInerney M; Sabik LM
Health Serv Res; 2019 Dec; 54(6):1233-1245. PubMed ID: 31576563
[TBL] [Abstract][Full Text] [Related]
70. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
Shavit O; Raz R; Stein M; Chodick G; Schejter E; Ben-David Y; Cohen R; Arbel D; Shalev V
Appl Health Econ Health Policy; 2012 Mar; 10(2):87-97. PubMed ID: 22201263
[TBL] [Abstract][Full Text] [Related]
71. Cost-benefit analysis on the HPV vaccine in Medicaid-enrolled females of the Appalachian region of Kentucky.
Prasad SR; Hill R
J Ky Med Assoc; 2008 Jun; 106(6):271-6. PubMed ID: 18630037
[TBL] [Abstract][Full Text] [Related]
72. HIV Screening Rates among Medicaid Enrollees Diagnosed with Other Sexually Transmitted Infections.
Adekeye OA; Abara WE; Xu J; Lee JM; Rust G; Satcher D
PLoS One; 2016; 11(8):e0161560. PubMed ID: 27556925
[TBL] [Abstract][Full Text] [Related]
73. Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ.
Liu J; Wang Y; Wan X; Zou J; Zhu Y; Lv W; Shen Y
J Gynecol Oncol; 2023 Jan; 34(1):e8. PubMed ID: 36424703
[TBL] [Abstract][Full Text] [Related]
74. Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.
Nguemeni Tiako MJ; Culhane J; South E; Srinivas SK; Meisel ZF
JAMA Netw Open; 2020 Dec; 3(12):e2029043. PubMed ID: 33306115
[TBL] [Abstract][Full Text] [Related]
75. The Breast and Cervical Cancer Prevention and Treatment Act in Georgia: effects on time to Medicaid enrollment.
Adams EK; Chien LN; Florence CS; Raskind-Hood C
Cancer; 2009 Mar; 115(6):1300-9. PubMed ID: 19189369
[TBL] [Abstract][Full Text] [Related]
76. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract][Full Text] [Related]
77. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
Patel AM; Chang E; Paydar C; Reddy SR
J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
[TBL] [Abstract][Full Text] [Related]
78. Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer - A population-based study.
Jensen PT; Schnack TH; Frøding LP; Bjørn SF; Lajer H; Markauskas A; Jochumsen KM; Fuglsang K; Dinesen J; Søgaard CH; Søgaard-Andersen E; Jensen MM; Knudsen A; Øster LH; Høgdall C
Eur J Cancer; 2020 Mar; 128():47-56. PubMed ID: 32109850
[TBL] [Abstract][Full Text] [Related]
79. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.
Wu EQ; Shi L; Birnbaum H; Hudson T; Kessler R
Psychol Med; 2006 Nov; 36(11):1535-40. PubMed ID: 16907994
[TBL] [Abstract][Full Text] [Related]
80. Assessing Telemedicine Utilization by Using Medicaid Claims Data.
Douglas MD; Xu J; Heggs A; Wrenn G; Mack DH; Rust G
Psychiatr Serv; 2017 Feb; 68(2):173-178. PubMed ID: 27691381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
